<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-rosetta-assets-from-merck/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-rosetta-assets-from-merck/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 19:43:29 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck &#124; Xconomy &#171; Biotech Beach Bum</title>
		<link>http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-rosetta-assets-from-merck/comment-page-1/#comment-63844</link>
		<dc:creator>Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck &#124; Xconomy &#171; Biotech Beach Bum</dc:creator>
		<pubDate>Thu, 04 Jun 2009 17:50:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=27427#comment-63844</guid>
		<description>[...] Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck &#124;&#160;Xconomy    This week Microsoft announced it will purchase the Rosetta Biosoftware division from Merck. This looks like a huge win/win/win combo; Merck gets out of a software business it doesn&#8217;t really &#8220;get&#8221;, Microsoft instantly becomes a serious player in the bioinformatics space with partnerships with Affymetrix and Illumina, and the biotech field gets serious software engineering for drug discovery and personal health. &#160;I&#8217;ll be at Microsoft&#8217;s Connected Health Conference next week and will report back on what I learn there! &#160;http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-roset... [...]</description>
		<content:encoded><![CDATA[<p>[...] Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck |&nbsp;Xconomy    This week Microsoft announced it will purchase the Rosetta Biosoftware division from Merck. This looks like a huge win/win/win combo; Merck gets out of a software business it doesn&#8217;t really &#8220;get&#8221;, Microsoft instantly becomes a serious player in the bioinformatics space with partnerships with Affymetrix and Illumina, and the biotech field gets serious software engineering for drug discovery and personal health. &nbsp;I&#8217;ll be at Microsoft&#8217;s Connected Health Conference next week and will report back on what I learn there! &nbsp;http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-roset&#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: White House report says fixing health care good for economy&#8230; Ya think? &#8212; MedCity morning read, June 2, 2009 : MedCity News</title>
		<link>http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-rosetta-assets-from-merck/comment-page-1/#comment-62844</link>
		<dc:creator>White House report says fixing health care good for economy&#8230; Ya think? &#8212; MedCity morning read, June 2, 2009 : MedCity News</dc:creator>
		<pubDate>Tue, 02 Jun 2009 11:38:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=27427#comment-62844</guid>
		<description>[...] Microsoft, dipping toe deeper into life sciences, buys Rosetta assets from Merck (Xconomy &#124; Seattle) [...]</description>
		<content:encoded><![CDATA[<p>[...] Microsoft, dipping toe deeper into life sciences, buys Rosetta assets from Merck (Xconomy | Seattle) [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
